The nation’s health-insurance markets aren’t getting any more consumer- or physician-friendly, and they are continuing to devolve further into a system that puts patients at risk of competitive harm.
A new report from the AMA shows that the stubborn state of “highly concentrated” health insurance markets is alive and well. Along with health insurer vertical integration, this isn’t just an economic issue, but an issue for patients, employers and physicians.
Across the country, the vast majority of health insurance markets remain highly concentrated. In many communities, insurers likely possess market power. When that happens, patients, employers and physicians can feel the consequences—higher premiums, fewer choices and lower physician earnings and employment.
“Health insurance markets across the country remain stubbornly concentrated, limiting competition and putting consumers at risk of higher costs and fewer choices,” said AMA President Willie Underwood III, MD, MSc, MPH. “New research confirms that insurer consolidation can drive up premiums, underscoring the real economic consequences of market power. Strengthening competition is essential to protecting consumers and making healthcare more affordable.”
The latest numbers and assessment come from the AMA’s 25th edition of the report, “Competition in Health insurance: A Comprehensive Study of U.S. Markets” (PDF). Researchers analyzed 2025 data from 385 metropolitan statistical areas that cover all 50 states and the District of Columbia. They found that:
- 95% of commercial markets—which include preferred provider organizations (PPOs), health maintenance organizations (HMOs), point of service plans (POSs) and exchanges—met the threshold of being “highly concentrated,” meaning that a market exceeds a regulatory threshold that federal guidelines establish and that the market lacks adequate health insurer competition.
- 90% of commercial markets had at least one insurer that had a market share of at least 30% and in 47% of markets, one insurer had a share of 50% or more.
- 97% of Medicare Advantage markets met the threshold of being “highly concentrated.”
- 88% of Medicare Advantage markets had an insurer where the market share is greater than 30% or more and 25% of markets had one insurer with a market share of 50% or greater.
“This research matters because competition matters,” says a letter from AMA CEO John Whyte, MD, MPH, that introduces the report’s findings. “When a handful of insurers dominate a market, patients face fewer choices, physicians have less negotiating power, and premiums and the quantity and quality of care can suffer. The findings from 2025 reveal a persistent challenge across the country: Health insurance markets remain highly concentrated, with a small number of insurers dominating both commercial insurance and Medicare Advantage.”
The AMA Division of Economic and Health Policy Research conducts independent research on competition in health insurance, pharmacy benefit manager (PBM) and hospital markets. Learn more.
Where is the least competition?
The “Competition in Health Insurance” report ranks the least competitive markets in the U.S. based on the Herfindahl-Hirschman Index scores that the federal government uses to measure market concentration and competition.
This number is important because, although conceptually health insurer mergers can have beneficial or harmful effects, only the negative effects have been seen to date, the report says. And it notes that proposed mergers and acquisitions involving health insurers should raise antitrust concerns.
“It appears that consolidation has resulted in the exercise of health insurer monopoly power— the ability to raise and maintain premiums above competitive levels—instead of the passing of benefits obtained through to consumers,” the report says.
The 10 states with the least competitive commercial health insurance markets in 2025 were:
- Alabama.
- Kentucky.
- Hawaii.
- Louisiana.
- Michigan.
- Illinois.
- Alaska.
- Indiana.
- Vermont.
- West Virginia.
The 10 states, including D.C., with the least competitive exchanges in 2025 were:
- District of Columbia.
- Rhode Island.
- Alaska.
- West Virginia.
- Vermont.
- Wyoming.
- Delaware.
- Hawaii.
- Connecticut.
- Arkansas.
And the 10 states, including D.C., with the least competitive Medicare Advantage markets in 2025 were:
- Wyoming.
- Vermont.
- District of Columbia.
- Rhode Island.
- Montana.
- Idaho.
- Oklahoma.
- Utah.
- Colorado.
- Louisiana.
Insurers also big in PBM markets
These latest findings on health insurance market concentration come on the heels of another AMA report showing that 94% of local U.S. pharmacy benefit manager (PBM) markets are also “highly concentrated."
Note the overlap on who the largest health insurers are nationally with the findings in the recent AMA Policy Research Perspectives report—“Competition in pharmacy benefit manager markets and vertical integration with insurers: 2026 Update:” The largest health insurers are also the largest PBMs. For example, that study shows that the four largest PBMs based on national market share in 2024 were:
- OptumRx—23%. Owned by UnitedHealth Group, which also is the largest commercial and Medicare Advantage health insurer nationwide with 15% and 30% market shares.
- Express Scripts—23%. Owned by The Cigna Group, which is the fourth largest with an 8% commercial health insurance market share.
- CVS/Caremark—18%. Owned by CVS Health, which operates the insurer Aetna, the second-biggest commercial health insurer, with 12% market share.
- Prime Therapeutics—11%. Owned collectively by several Blue Cross and Blue Shield health insurers, including Health Care Service Corp. and Blue Cross Blue Shield of Florida, both of which are among the largest commercial insurers nationally, as well as others that are generally the largest in their local areas.
The report concludes that the majority of health insurance markets are prone to health insurers exercising market power. The AMA will continue to monitor competition in health-insurance markets and assess proposed health insurer mergers as well as their integration with firms in PBM markets.
“Health insurers may continue attempts to get bigger—either horizontally, vertically or by engaging in cross-market mergers—in order to have a larger footprint across the healthcare landscape,” the report concludes. “This growth risks lowering competition in healthcare markets and increasing the detrimental effects associated with less competition.”